Contingency-fee state and city suits against opioid makers

They capitalize on widespread public anger and frustration at the addiction epidemic, but face formidable legal hurdles — among them the fact that the marketing practices and language the suits assail as unlawful were often specifically approved by the federal Food and Drug Administration. Much impetus for the suits comes from private law firms that pitch the actions to governments as free, while setting themselves up for gigantic contingency fees after the eventual settlement. [Nate Raymond, Reuters]

Comments are closed.